Development of a standardized methodology for double-blind, placebo-controlled food challenge in patients with brittle asthma and perceived food intolerance
Jc. Baker et al., Development of a standardized methodology for double-blind, placebo-controlled food challenge in patients with brittle asthma and perceived food intolerance, J AM DIET A, 100(11), 2000, pp. 1361-1367
Objective To develop a standardized, double-blind, placebo-controlled, food
challenge (DBPCFC) methodology for identifying food intolerance in patient
s with brittle asthma.
Subjects/setting Patients with brittle asthma and perceived food intoleranc
e were studied in hospital.
Design Each of 3 protocols began with 5 days of dietary exclusion. Protocol
1 consisted of open food challenges in 29 patients, protocol 2 consisted o
f 2 daily DBPCFCs in 22 patients, and protocol 3 involved 1 daily DBPCFC in
18 patients. Total immunoglobulin E level was measured and food-specific r
adioallergosorbent tests and skin prick tests were conducted. A standard pa
nel of hyperallergenic foods were masked in a soup (developed specially for
this study) for every food challenge. Peak expiratory flow, forced expirat
ory volume, and symptoms were assessed as objective measures of response. O
pen food challenges at home followed each protocol. Each protocol took appr
oximately 14 days in the hospital and 4 to 6 months at home.
Results For protocols 1, 2 and 3, positive reactions were experienced by 52
%, 55%, and 66% of patients, respectively. Radioallergosorbent tests and sk
in prick tests were shown to have 40% and 71% sensitivity, respectively, an
d 74% and 77% specificity for predicting a positive food challenge.
Applications/conclusions The high prevalence of food intolerance in patient
s with brittle asthma was confirmed, as was the poor positive predictive va
lue of skin prick tests and radioallergosorbent tests. The food challenge m
ethod developed enables standardized identification of food intolerances in
patients with brittle asthma and may be useful in other groups.